Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.

Familial hypercholesterolemia (FH) is a condition caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Expression of LDLR is highly regulated and excess receptor expression is cytotoxic. To incorporate essential gene regulation into a gene therapy vector for FH, we generated vect...

Full description

Bibliographic Details
Main Authors: Hibbitt, O, McNeil, E, Lufino, M, Seymour, L, Channon, K, Wade-Martins, R
Format: Journal article
Language:English
Published: 2010
_version_ 1797102399383404544
author Hibbitt, O
McNeil, E
Lufino, M
Seymour, L
Channon, K
Wade-Martins, R
author_facet Hibbitt, O
McNeil, E
Lufino, M
Seymour, L
Channon, K
Wade-Martins, R
author_sort Hibbitt, O
collection OXFORD
description Familial hypercholesterolemia (FH) is a condition caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Expression of LDLR is highly regulated and excess receptor expression is cytotoxic. To incorporate essential gene regulation into a gene therapy vector for FH, we generated vectors in which the expression of therapeutic human LDLR gene, or luciferase reporter gene, is driven by 10 kb of human LDLR genomic DNA encompassing the promoter region including elements essential for physiologically regulated expression. Using luciferase expression and specific LDL binding and internalization assays, we have shown in vitro that the genomic promoter element confers long-term, physiologically regulated gene expression and complementation of receptor deficiency in culture for 240 cell-generations. This was demonstrated in the presence of sterols or statins, modifiers of LDLR promoter activity. In vivo, we demonstrate efficient liver-specific delivery and expression of luciferase following hydrodynamic tail-vein injection and confirm that expression from the LDLR promoter element is sensitive to statin administration. We also demonstrate long-term LDLR expression from the 10-kb promoter element up to 9 months following delivery. The vector system that we describe provides the efficient delivery, long-term expression, and physiological regulation required for a successful gene therapy intervention for FH.
first_indexed 2024-03-07T06:05:28Z
format Journal article
id oxford-uuid:edaf9923-ebcf-45f0-a2b4-bf1234f57f69
institution University of Oxford
language English
last_indexed 2024-03-07T06:05:28Z
publishDate 2010
record_format dspace
spelling oxford-uuid:edaf9923-ebcf-45f0-a2b4-bf1234f57f692022-03-27T11:26:58ZLong-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:edaf9923-ebcf-45f0-a2b4-bf1234f57f69EnglishSymplectic Elements at Oxford2010Hibbitt, OMcNeil, ELufino, MSeymour, LChannon, KWade-Martins, RFamilial hypercholesterolemia (FH) is a condition caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Expression of LDLR is highly regulated and excess receptor expression is cytotoxic. To incorporate essential gene regulation into a gene therapy vector for FH, we generated vectors in which the expression of therapeutic human LDLR gene, or luciferase reporter gene, is driven by 10 kb of human LDLR genomic DNA encompassing the promoter region including elements essential for physiologically regulated expression. Using luciferase expression and specific LDL binding and internalization assays, we have shown in vitro that the genomic promoter element confers long-term, physiologically regulated gene expression and complementation of receptor deficiency in culture for 240 cell-generations. This was demonstrated in the presence of sterols or statins, modifiers of LDLR promoter activity. In vivo, we demonstrate efficient liver-specific delivery and expression of luciferase following hydrodynamic tail-vein injection and confirm that expression from the LDLR promoter element is sensitive to statin administration. We also demonstrate long-term LDLR expression from the 10-kb promoter element up to 9 months following delivery. The vector system that we describe provides the efficient delivery, long-term expression, and physiological regulation required for a successful gene therapy intervention for FH.
spellingShingle Hibbitt, O
McNeil, E
Lufino, M
Seymour, L
Channon, K
Wade-Martins, R
Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title_full Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title_fullStr Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title_full_unstemmed Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title_short Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
title_sort long term physiologically regulated expression of the low density lipoprotein receptor in vivo using genomic dna mini gene constructs
work_keys_str_mv AT hibbitto longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs
AT mcneile longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs
AT lufinom longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs
AT seymourl longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs
AT channonk longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs
AT wademartinsr longtermphysiologicallyregulatedexpressionofthelowdensitylipoproteinreceptorinvivousinggenomicdnaminigeneconstructs